FWM
TEVA icon

FFT Wealth Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

FFT Wealth Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-25,292
Closed -$840K – 69
2017
Q2 		$840K Hold
25,292
– – 0.27% 37
2017
Q1 		$812K Sell
25,292
-36,206
-59% -$1.24M 0.26% 42
2016
Q4 		$2.23M Buy
61,498
+47,160
+329% +$1.88M 0.51% 27
2016
Q3 		$655K Buy
+14,338
New +$748K 0.28% 34

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
Abrams Capital Management
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

FFT Wealth Management's TEVA Position: Q3 2017 in Review

FFT Wealth Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2017, closing a stake of 25,292 shares — an estimated $840K sold.

FFT Wealth Management first reported a position in TEVA in Q3 2016 and held it in 4 quarters. The position peaked at $2.23M in Q4 2016. 537 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • FFT Wealth Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2017 after selling out during the quarter.
  • FFT Wealth Management sold 25,292 Teva Pharmaceutical Industries Limited shares in Q3 2017, an estimated $840K.
  • FFT Wealth Management first reported a position in Teva Pharmaceutical Industries Limited in Q3 2016 and held it in 4 quarters.
  • FFT Wealth Management's Teva Pharmaceutical Industries Limited position peaked at $2.23M in Q4 2016.
  • 537 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2017.

Based on FFT Wealth Management's 13F filing for Q3 2017, filed 14 Nov 2017.